Folligon-Pmsg - 25ml

CATTLE: Respiratory bacterial infections, soft tissue infections, metritis and mastitis. Withdrawel: MEAT AND OFFAL: 42 days, MILK: 80 hours PIGS: Respiratory bacterial infections in growing pigs, Colibacillosis and periparturient infections in sows. Withdrawal: MEAT AND OFFAL:31 days. DOG AND CATS: Respiratory tract infections, urinary tract infections and skin and soft tissue infections. Dosage: 1ml/20kg intramuscular or subcutaneous injection daily for 3-5 days. Active ingredient: Amoxicillin, Clavulanic

CATTLE: Respiratory bacterial infections, soft tissue infections, metritis and mastitis. Withdrawel: MEAT AND OFFAL: 42 days, MILK: 80 hours PIGS: Respiratory bacterial infections in growing pigs, Colibacillosis and periparturient infections in sows. Withdrawal: MEAT AND OFFAL:31 days. DOG AND CATS: Respiratory tract infections, urinary tract infections and skin and soft tissue infections. Dosage: 1ml/20kg intramuscular or subcutaneous injection daily for 3-5 days. Active ingredient: Amoxicillin, Clavulanic

A live vaccine against canine infectious tracheobronchitis caused by B. bronchiseptica and parainfluenza virus in dogs. Infectious tracheobronchitis is a highly contagious, multi-factorial disease of the dog’s respiratory tract. Bordetella bronchiseptica and canine parainfluenza are the most common bacterial and viral agents associated with the disease. Environmental factors such as stress, ventilation and climate may also contribute. Nobivac KC is a low volume dose (0.4ml), easy to administer, intranasal vaccine which acts against both the key causative agents of infectious tracheobronchitis and provides protection within 72 hours and lasts for at least 12 months. It can be used in puppies as young as three weeks and in pregnant bitches.

A combined live freeze-dried vaccine against canine distemper, infectious canine hepatitis, canine parvovirus and canine parainfluenza virus type 2. Each 1-ml dose of vaccine contains attenuated canine distemper virus, at least 104.0 CCID50, attenuated canine adenovirus (CAV2), at least 102.5 CCID50, attenuated canine parvovirus, at least 104.9 CCID50, attenuated canine parainfluenza type 2 virus, at least 104.7 CCID50 Uses Dogs and puppies from 8 weeks of age: Active immunization against distemper to reduce mortality and clinical signs; against infectious canine hepatitis to prevent clinical signs; against parvovirus to prevent clinical signs and reduce mortality and viral excretion; and against parainfluenza type 2 infections to reduce clinical signs and viral excretion. Onset of immunity: 2 weeks after completion of the primary vaccination course. Duration of immunity: 1 year. Dosage and administration Reconstitute the vaccine with Eurican L using a clean sterile syringe. Use the vaccine immediately after reconstitution of the freeze-dried pellet. Apply usual aseptic procedures. Use sterile and/or disinfectant-free equipment for injection purposes. Administer by subcutaneous injection. The following vaccination schedule is recommended: Primary vaccination: 1st injection: from 8th week of age. 2nd injection: 3 to 5 weeks later, from 12th week of age. Revaccination: Booster injections should be given annually thereafter.